Medicine
-
FDA Approves Tirzepatide to Reduce Heart Attack Risk in Type 2 Diabetes
The FDA has approved tirzepatide (Mounjaro) for cardiovascular risk reduction, marking a shift from glucose-only control to comprehensive heart protection based on…
-
Waters and Labcorp partner to expand FDA-approved HPV testing options by late 2026
Diagnostic leaders aim to reshape cervical cancer screening availability through a nationwide network offering comprehensive genotyping via clinician-collected and at-home samples.
-
RFK Jr. Orders FDA to Allow Unapproved Peptide Injections
Health Secretary Robert F. Kennedy Jr. orders the FDA to halt enforcement on six unapproved wellness peptides, prompting safety concerns from scientists…
-
FDA Draft Guidance Would Let Individualized Gene Editing Variants Share One License Application
New regulatory framework aims to streamline submissions for multiple gene therapy variants under a single application, addressing critical gaps in oversight for…
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
Court rulings on liability and funding disputes force patients to wait years for verdicts, while Medicare recovery rules threaten to consume settlement…
-
Stanford Digital Twins Point to a Drug Pair That May Delay Preterm Labor
Researchers use immune system simulations to find a drug pair that delays labor 15 times better than aspirin alone, offering hope for…
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
MSI-H status identifies rectal cancer patients who may avoid surgery via dostarlimab, a new FDA-approved immunotherapy targeting defective DNA repair.
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
A smooth protein surface and high GTP affinity stymied drugmakers until a cysteine at G12C enabled covalent inhibitors like divarasib.
-
What Clinical Trials Really Show About Tigilanol Tiglate from the Blushwood Berry
A viral social media post revived interest in the rainforest drug, but current human trials reveal targeted local results rather than a…
-
MK615 Apricot Extract: Lab Promise vs. Limited Human Trial Data
While viral clips claim MK615 kills 95% of cancer cells, a small Phase I trial showed only disease stabilization, not tumor shrinkage,…
-
Long COVID Linked to 14 Percent Higher Risk of New High Blood Pressure, Swedish Study Finds
Discover the new study linking Long COVID to a 14 percent higher risk of hypertension, and learn why cardiovascular monitoring matters now.
-
Understanding CIPI: Envita Medical Centers’ In-Tumor Injection Treatment
A neutral explainer detailing what Chemo Immuno Precision Injections are, how the procedure works at Envita Medical Centers, and its evidence status.
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
China’s approval of satri-cel marks a milestone for solid tumor treatment, introducing a targeted cellular therapy for advanced gastric cancer.
-
FDA Approves At-Home Subcutaneous Skyrizi Start for Adults With Crohn’s Disease
Examining the clinical performance, mechanism, and market impact of AbbVie’s IL-23 inhibitor following its latest subcutaneous induction approval.
-
Viatris Secures FDA Approval for RYZUMVI to Treat Presbyopia in Adults
Viatris wins FDA approval for RYZUMVI to treat presbyopia, adding a new option for aging eyes while seeking a U.S. commercial partner.
-
European Regulators Back Breakthrough Pancreatic Cancer Drug Rasonque
The EMA has recommended approval for daraxonrasib, a daily pill that doubles survival rates for patients with metastatic pancreatic adenocarcinoma.
-
Thyroid Eye Disease Affects 16 in 100,000 Women Yearly, Smoking Multiplies Risk
Thyroid eye disease, linked to Graves’ disease, occurs in 16 per 100,000 women annually, with smoking increasing risk nearly eightfold and severe…
-
Generalized Myasthenia Gravis: Autoimmune Attack on Nerve-Muscle Junction Causes Progressive Weakness
Generalized myasthenia gravis is an autoimmune disorder where antibodies destroy acetylcholine receptors, leading to muscle weakness that worsens with activity and improves…
-
Two FDA-Approved MASH Drugs Give Patients New Options, and UCLA Health Offers a Way to Choose
LOS ANGELES, October 14 — On this date, the U.S. Food and Drug Administration granted approval to two drugs, Resmetirom and semaglutide,…
-
Doctors Investigate Environmental and Lifestyle Factors Behind Millennial Rectal Cancer Rise
Doctors are asking a hard question about people born after 1980. They want to know what changed. Rectal cancer is rising in…
-
New Blood Test Detects Pancreatic Cancer at Precancerous Stage
BALTIMORE, September 17 — A new liquid biopsy blood test can detect pancreatic cancer at its earliest stages, including when it is…
-
PAHO Opens HIV Prevention Injection Access for Fourteen Nations
WASHINGTON, September 15 — The Pan American Health Organization announced a new pathway on Tuesday that will let 14 countries in Latin…
-
UF Launches G-CARE to Monitor Senior Health Remotely
GAINESVILLE, September 15 — The University of Florida has unveiled a federally funded project to turn the ordinary smartphone into a remote…
-
Insilico Medicine Launches Longevity Vaccines Research Initiative Targeting Aging Diseases
HONG KONG, September 15 — Insilico Medicine is taking its AI drug-discovery engine into preventive medicine. The Hong Kong-listed company (HKEX: 3696)…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992